國際交流

Time

Topic

Speaker/ Moderator

08:30~09:00

Registration

09:00~09:10

Opening Remark

Wei J. Chen (陳為堅), M.D. Sc.D.

Director / Distinguished Investigator

Center for Neuropsychiatric Research, National Health Research Institutes.

Yung-Hsiao Chiang(蔣永孝), M.D. Ph.D.

Director, TMU Neuroscience Research Center

Chaur-Jong Hu (胡朝榮), M.D.

Professor/ Director, Ph.D. Program in Medical Neuroscience, TMU

Professor/ Director, International Master Program in Medical Neuroscience, TMU

Professor, Department of Neurology
Deputy Director, College of Medicine, Taipei Medical University
Deputy Superintendent, TMU Neuroscience Research Center, Taipei Medical University

09:10~09:20

Group photo

09:15~09:30

The GLP-1/GIP (Incretin) System and Neurodegenerative Disorders:
New Wine in Old Bottles

Barry Hoffer, MD., Ph.D.

Department of Neurosurgery, Case Western Reserve University School of Medicine Cleveland, Ohio

09:30~09:35

Discussion

Jian-Ying Chuang (莊健盈), Ph.D.

Professor, International Master Program in Medical Neuroscience, TMU

Vice Dean, College of Medical Science and Technology, TMU

09:35~09:50

Psilocybin reduces ischemic brain injury in rats

Seong Jin Yu (劉誠珍), Ph.D.

Associate Investigator, Center for Neuropsychiatric Research, National Health Research Institutes.

09:50~09:55

Discussion

Jian-Ying Chuang (莊健盈), Ph.D.

Professor, International Master Program in Medical Neuroscience, TMU

Vice Dean, College of Medical Science and Technology, TMU

09:55~10:10

TDP-43 function in neural circuit formation

Tzu-Jen Kao (高祖仁), Ph.D.

Professor, International Master Program in Medical Neuroscience, TMU

10:10~10:15

Discussion

Jian-Ying Chuang (莊健盈), Ph.D.

Professor, International Master Program in Medical Neuroscience, TMU

Vice Dean, College of Medical Science and Technology, TMU

10:15~10:35

Coffee Break

10:35~10:50

Developing new treatment strategies for inflammatory and neurodegenerative disorders: new thalidomide-like drugs without cereblon binding

Nigel Greig, Ph.D.

Senior Investigator, Drug Design & Development Section, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA

10:50~10:55

Discussion

Szu-Yi Chou (周思怡), Ph.D.

Professor, Ph.D. Program in Medical Neuroscience, TMU

10:55~11:10

Neurofilament light chain (NFL) indicated Neurotoxicity in Substance Use Disorder Patients

Yu-Li Liu (劉玉麗), Ph.D.

Investigator, Center for Neuropsychiatric Research, National Health Research Institutes.

11:10~11:15

Discussion

Szu-Yi Chou (周思怡), Ph.D.

Professor, Ph.D. Program in Medical Neuroscience, TMU

11:15~11:30

Reprogramming of fatty acid metabolism confers to temozolomide resistance in glioblastoma

Tsung- I Hsu (徐宗溢), Ph.D.

Assistant Professor, Ph.D. Program in Medical Neuroscience, TMU

11:30~11:35

Discussion

Szu-Yi Chou (周思怡), Ph.D.

Professor, Ph.D. Program in Medical Neuroscience, TMU

11:35~11:50

Combination of NP106 and TML-6 for the treatment of Alzheimer’s disease

Feng-Shiun Shie (謝奉勳), Ph.D.

Investigator, Center for Neuropsychiatric Research, National Health Research Institutes.

11:50~11:55

Discussion

Szu-Yi Chou (周思怡), Ph.D.

Professor, Ph.D. Program in Medical Neuroscience, TMU

11:55~12:00

Closing Remark

Yi-Chao Lee (李宜釗), Ph.D.

Professor, Ph.D. Program in Medical Neuroscience, TMU